Catalyst Capital adds to investment in Evolve Biologics
Evolve Biologics, the plasma-derived therapeutics affiliate of Toronto-based Therapure Biopharma, has raised financing from majority investor Catalyst Capital Group.
10 March 2021•3 mins read
Evolve Biologics, the plasma-derived therapeutics affiliate of Toronto-based Therapure Biopharma, has raised financing from majority investor Catalyst Capital Group.
Truelink Capital agrees to carve-out of Johnson Controls’ global intrusion products business
1 hour ago · 2 mins read
Victor Capital-backed Adventure Ready Brands buys waterless hygiene maker CleanLife
1 hour ago · 1 min read
Eurazeo’s Christophe Bavière: Diversifying Europe’s mid-market
3 hours ago · 7 mins read
Main Capital Partners’ Ferranti agrees to acquire Belgian energy software firm Cogenius
4 hours ago · 2 mins read
Leon Capital backs data center infra biz VKE in ‘highly dynamic’ sector
6 hours ago · 2 mins read
Bertram Capital buys industrial distributor Motion & Control Enterprises from Frontenac
19 hours ago · 2 mins read
Peak Rock’s California Custom Fruits & Flavors buys Skjodt-Barrett nutritional ingredients unit
20 hours ago · 1 min read
